Publicacions en què col·labora amb Enrique Echevarría Orella (51)

2020

  1. Synovial fluid peptidase activity as a biomarker for knee osteoarthritis clinical progression: A cross-sectional study

    Bone and Joint Research, Vol. 9, Núm. 11, pp. 789-797

2008

  1. Brain endocannabinoid system is invoived in fluoxetine-induced anorexia

    Nutritional Neuroscience, Vol. 11, Núm. 3, pp. 111-118

  2. Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats

    Neuropeptides, Vol. 42, Núm. 3, pp. 293-299

  3. Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: Effects of chronic fluoxetine treatment

    Brain Research, Vol. 1236, pp. 57-72

  4. Type 1 diabetes alters brain cannabinoid receptor expression and phosphorylation status in rats

    Hormone and Metabolic Research, Vol. 40, Núm. 7, pp. 454-458

2004

  1. Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain

    Psychopharmacology, Vol. 176, Núm. 3-4, pp. 305-311

  2. Effects of fluoxetine administration on regional galanin expression in obese Zucker rat hypothalamus

    Nutritional Neuroscience, Vol. 7, Núm. 3, pp. 171-175

  3. Fluoxetine alters mu opioid receptor expression in obese Zucker rat hypothalamus

    Neuroscience Research Communications, Vol. 35, Núm. 1, pp. 1-7

  4. Toluene alters appetite, NPY, and galanin immunostaining in the rat hypothalamus

    Neurotoxicology and Teratology, Vol. 26, Núm. 2, pp. 195-200

2003

  1. Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins

    Nutritional Neuroscience, Vol. 6, Núm. 2, pp. 102-111

2002

  1. Effects of fluoxetine administration on neuropeptide Y and orexins in obese Zucker rat hypothalamus

    Obesity Research, Vol. 10, Núm. 6, pp. 532-540

  2. Nefazodone alters NPY immunostaining in rat arcuate-paraventricular projection without changes in food intake and body weight

    Nutritional Neuroscience, Vol. 5, Núm. 5, pp. 353-358

  3. Selective serotonin reuptake inhibitors alter NPY immunostaining in the rat hypothalamus

    Neuroscience Research Communications, Vol. 30, Núm. 3, pp. 185-196

2001

  1. Chronic amphetamine administration decreases D2 dopamine receptor immunostaining in the lateral habenular nucleus

    Neuroscience Research Communications, Vol. 29, Núm. 1, pp. 59-68

2000

  1. Comparison of the effects of the administration of fluoxetine and sertraline on the immune markers of the mu opioid receptor in the rat brain

    Revista de neurologia, Vol. 31, Núm. 10, pp. 919-922

  2. Lithium alters mu-opioid receptor expression in the rat brain

    Neuroscience Letters, Vol. 279, Núm. 1, pp. 9-12

1999

  1. Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain

    Brain Research, Vol. 817, Núm. 1-2, pp. 236-240

  2. Infraorbital Nerve Transection Increases NADPH-diaphorase Activity in the Rat Mesencephalic Trigeminal Nucleus

    Journal of Brain Research, Vol. 39, Núm. 4, pp. 567-571

  3. Infraorbital nerve transection increases NADPH-diaphorase activity in the rat mesencephalic trigeminal nucleus

    JOURNAL OF BRAIN RESEARCH-JOURNAL FUR HIRNFORSCHUNG, Vol. 39, Núm. 4, pp. 567-571

1998

  1. Effects of acute benzene exposure on brain enkephalin immunostaining and degradation

    Neurotoxicology and Teratology, Vol. 20, Núm. 6, pp. 611-616